1. Home
  2. AZTA vs RAPP Comparison

AZTA vs RAPP Comparison

Compare AZTA & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$20.15

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$27.05

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTA
RAPP
Founded
1978
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
AZTA
RAPP
Price
$20.15
$27.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$42.60
$48.50
AVG Volume (30 Days)
826.8K
292.7K
Earning Date
05-06-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
60.52
24.34
EPS
N/A
N/A
Revenue
$593,821,000.00
N/A
Revenue This Year
$6.52
N/A
Revenue Next Year
$5.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.22
$7.73
52 Week High
$41.73
$42.27

Technical Indicators

Market Signals
Indicator
AZTA
RAPP
Relative Strength Index (RSI) 21.98 45.42
Support Level N/A $26.67
Resistance Level $32.18 $29.51
Average True Range (ATR) 1.15 1.88
MACD -0.03 -0.31
Stochastic Oscillator 0.08 27.77

Price Performance

Historical Comparison
AZTA
RAPP

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: